On August 26, Amgen (AMGN) announced the purchase of leading immunology drug Otezla from Celgene (CELG) for a cash consideration of $13.4 billion.
https://marketrealist.com/2019/08/amgen-celgenes-otezla-deal-key-highlights/
Market Realist
This site is not involved in the creation of this post.
